Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Robert S. Brown Jr."'
Autor:
Nicole T. Shen, Alyson Kaplan, Khalid Fahoum, Elora Basu, Akhil Shenoy, Nabeel Wahid, Amanda Ivatorov, Joseph Pisa, Annaheta Salajegheh, Enad Dawod, Russell Rosenblatt, Brett Fortune, Monika Safford, Robert S. Brown Jr.
Publikováno v:
Hepatology Communications, Vol 5, Iss 7, Pp 1156-1164 (2021)
Abstinence in patients with alcohol‐associated liver disease (ALD) reduces mortality. Most predictors of relapse are not quantifiable, preventing objective analysis of relapse risk and targeted intervention to improve clinical outcomes. We prospect
Externí odkaz:
https://doaj.org/article/4932055f87504475ad936f3c809a17a4
Autor:
Kavita Radhakrishnan, Adrian M. Di Bisceglie, K. Rajender Reddy, Joseph K. Lim, Josh Levitsky, Mohamed A. Hassan, Jama M. Darling, Jordan J. Feld, Lucy Akushevich, Monika Vainorius, David R. Nelson, Michael W. Fried, Robert S. Brown Jr., Norah A. Terrault
Publikováno v:
Hepatology Communications, Vol 3, Iss 10, Pp 1388-1399 (2019)
Recent studies have suggested a negative impact of hepatocellular carcinoma (HCC) on sustained virologic response (SVR) to hepatitis C virus (HCV) direct acting antivirals (DAAs). We compared the effectiveness of DAAs in patients with cirrhosis, with
Externí odkaz:
https://doaj.org/article/4e9e0104dcf848c6a5db6f6caa6f34fe
Autor:
Eric M. Yoshida, Paul Kwo, Kosh Agarwal, Christophe Duvoux, François Durand, Markus Peck-Radosavljevic, Leslie Lilly, Bernard Willems, Hugo Vargas, Princy Kumar, Robert S. Brown Jr., Yves Horsmans, Shampa De-Oertel, Sarah Arterburn, Hadas Dvory-Sobol, Diana M. Brainard, John G. McHutchison, Norah Terrault, Mario Rizzetto, Beat Müllhaupt
Publikováno v:
Annals of Hepatology, Vol 16, Iss 3, Pp 375-381 (2017)
Introduction: Recurrence of HCV infection in patients with chronic hepatitis C virus (HCV) at the time of liver transplantation is nearly universal and reduces the likelihood of graft and patient survival. Materials and methods: We evaluated outcomes
Externí odkaz:
https://doaj.org/article/7b99e5b0953345a782fe2e657a4e893c
Autor:
Brian McMahon, Chari Cohen, Robert S Brown Jr, Hashem El-Serag, George N Ioannou, Anna S Lok, Lewis R Roberts, Amit G Singal, Timothy Block
Publikováno v:
JNCI Cancer Spectrum. 7
Death rates from primary liver cancer (hepatocellular carcinoma [HCC]) have continued to rise in the United States over the recent decades despite the availability of an increasing range of treatment modalities, including new systemic therapies. Prog
Publikováno v:
European Medical Journal Hepatology, Vol 4, Iss 1, Pp 32-40 (2016)
The symposium addressed the efficacy and safety of compounds currently available for treatment of hepatitis C virus (HCV) and chronic kidney disease (CKD) in North American and European countries, comparing data from trials and clinical practice. Pro
Externí odkaz:
https://doaj.org/article/3a5616d193e34c5ba301ffb3582b73cc
Autor:
David M. Salerno, Douglas L. Jennings, Nicholas W. Lange, Danielle (Bley) Kovac, Tara Shertel, Justin K. Chen, Jessica Hedvat, Jenna Scheffert, Robert S. Brown Jr, Marcus R. Pereira
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 22(8)
Nirmatrelvir/ritonavir (NR) use has not yet been described in solid organ transplant recipients (SOTRs) with mild COVID-19. The objective was to evaluate outcomes among SOTR and describe the drug-drug interaction of NR. This is an IRB-approved, retro
Publikováno v:
Clinical Liver Disease. 10:79-81
Autor:
Robert S. Brown Jr
Dr. Brown provides a timely upate on the clinical diagnosis and management of Hepatic Encephalopathy. His issue addresses current hot topics including Role of NH4 in Pathogenesis of Hepatic Encephalopathy; How to diagnose and manage HE in fulminant h
Publikováno v:
Clinical Liver Disease. 1:73-76
Hepatitis C virus (HCV) is a leading cause of cirrhosis and hepatocellular carcinoma (HCC) and is the most common in- dication for liver transplantation (LT) in the United States and Europe. In contrast to other indications for LT, HCV re- currence a
Publikováno v:
Hepatology. 47:1427-1427